Psychiatry and Neurology, Neurology · Orange, CA
NPI
1578986949
Since 2014
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
200 S Manchester Ave, Suite 206
Orange, CA, 92868
Phone (714) 456-7637
Groups this clinician bills Medicare through
Medicare paid, 2024
$90K
1,078 services
Medicare patients, 2024
333
Average age 74
Drug cost, 2024
$1.3M
1,991 prescriptions
Company payments, 2023
$180
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nicolas Phielipp was code 99215 (office e&m - established), 330 times for 192 patients. In total Nicolas Phielipp billed 1,078 services in 27 codes, and Medicare paid $90K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-03-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 330 | 192 | $119.40 | $39K |
| 99214 Office E&M - Established | Office | 180 | 132 | $80.20 | $14K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 162 | 118 | $14.32 | $2,320 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 59 | 40 | $25.87 | $1,527 |
| 99205 Office E&M - New | Office | 42 | 42 | $147.98 | $6,215 |
| 64611 Musculoskeletal | Office | 41 | 15 | $94.00 | $3,854 |
| 64616 Musculoskeletal | Office | 39 | 12 | $109.86 | $4,285 |
| 64612 Musculoskeletal | Office | 31 | 11 | $145.92 | $4,524 |
| 99213 Office E&M - Established | Office | 20 | 16 | $53.06 | $1,061 |
| 95983 Electrical Nerve Conductivity | Office | 17 | 11 | $41.49 | $705 |
| 95970 Electrical Nerve Conductivity | Office | 13 | 11 | $15.79 | $205 |
By year: 2022 $96K for 1,089 services; 2023 $90K for 970 services; 2024 $90K for 1,078 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nicolas Phielipp prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 540 prescriptions and refills. In total Nicolas Phielipp wrote 1,991 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 540 | 1,410 | 162 | $31K |
| Rasagiline Mesylate Generic | 108 | 260 | 28 | $30K |
| Gabapentin Generic | 103 | 245 | 29 | $4,956 |
| Austedo Deutetrabenazine | 89 | 93 | Under 11 | $686K |
| Quetiapine Fumarate Generic | 77 | 197 | 22 | $2,303 |
| Rytary Carbidopa/Levodopa | 75 | 134 | 18 | $140K |
| Clozapine Generic | 74 | 76 | Under 11 | $1,141 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 67 | 187 | 20 | $1,969 |
| Clonazepam Generic | 47 | 124 | 20 | $769 |
| Donepezil Hcl Generic | 44 | 114 | 18 | $632 |
| Primidone Generic | 38 | 92 | Under 11 | $1,136 |
| Midodrine Hcl Generic | 34 | 52 | Under 11 | $1,676 |
| Carbidopa Generic | 30 | 60 | Under 11 | $11K |
| Amitriptyline Hcl Generic | 28 | 74 | Under 11 | $252 |
| Alprazolam Generic | 27 | 35 | Under 11 | $96.63 |
Brand drugs: 375 claims; generic drugs: 1,616 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Nicolas Phielipp $180 ($180 in general payments such as food, travel and fees) from 1 company. The largest payer was Boston Scientific Corporation with $180.
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation BSX | 1 | $180 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.